Humoral and lung immune responses to Mycobacterium tuberculosis infection in a primate model of protection

Trials in Vaccinology

Volumn 3, Issue 1, 2014, Pages 47-51

  Dutta, Noton K ^a,c   McLachlan, James ^b   Mehra, Smriti ^a,b   Kaushal, Deepak ^a,b  

^a TULANE NATIONAL PRIMATE RESEARCH CENTER   (United States)

^b TULANE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Animal model; BCG; Granuloma; Lymphocyte; M. tuberculosis; Macrophage

Indexed keywords

BCG VACCINE; ALPHA CHEMOKINE; BETA CHEMOKINE; CD4 ANTIGEN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BCG VACCINATION; CD3+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; EFFECTOR CELL; HUMORAL IMMUNITY; IMMUNOCOMPETENT CELL; IMMUNOPHENOTYPING; INFECTION PREVENTION; LUNG LAVAGE; LYMPHOCYTE COUNT; MACACA; MACROPHAGE; NONHUMAN; PRIORITY JOURNAL; TUBERCULOSIS; ANIMAL CELL; IN VIVO STUDY; LUNG TUBERCULOSIS; MACACA FASCICULARIS; MYCOBACTERIUM TUBERCULOSIS; PRIMATE MODEL;

EID: 84897522672     PISSN: None     EISSN: 18794378     Source Type: Journal    
DOI: 10.1016/j.trivac.2014.02.001     Document Type: Article

References (36)

1. C. Dye Global epidemiology of tuberculosis Lancet 367 2006 938 940
2. L. Phillips Infectious disease: TB's revenge Nature 493 2013 14 16
3. N.R. Gandhi, A. Moll, A.W. Sturm, R. Pawinski, T. Govender, and U. Lalloo et al. Extensively drug-resistant tuberculosis as a cause of death in patients co-infected with tuberculosis and HIV in a rural area of South Africa Lancet 368 2006 1575 1580 (Pubitemid 44780738)
4. I.M. Orme Prospects for new vaccines against tuberculosis Trends Microbiol. 3 1995 401 404
5. P.E. Fine Variation in protection by BCG: implications of and for heterologous immunity Lancet 346 1995 1339 1345
6. A. Lalvani, S. Sridhar, and C.F. von Reyn Tuberculosis vaccines: time to reset the paradigm? Thorax 68 2013 1092 1094
7. T.H. Ottenhoff, and S.H. Kaufmann Vaccines against tuberculosis: where are we and where do we need to go? PLoS Pathog. 8 2012 e1002607
8. D.N. McMurray A nonhuman primate model for preclinical testing of new tuberculosis vaccines Clin. Infect. Dis. 30 Suppl. 3 2000 S210 S212
9. S.A. Sharpe, H. McShane, M.J. Dennis, R.J. Basaraba, F. Gleeson, and G. Hall et al. Establishment of an aerosol challenge model of tuberculosis in rhesus macaques and an evaluation of endpoints for vaccine testing Clin. Vaccine Immunol.: CVI 17 2010 1170 1182
10. N.K. Dutta, S. Mehra, P.J. Didier, C.J. Roy, L.A. Doyle, and X. Alvarez et al. Genetic requirements for the survival of tubercle bacilli in primates J. Infect. Dis. 201 2010 1743 1752
11. S. Mehra, X. Alvarez, P.J. Didier, L.A. Doyle, J.L. Blanchard, and A.A. Lackner et al. Granuloma correlates of protection against tuberculosis and mechanisms of immune modulation by Mycobacterium tuberculosis J. Infect. Dis. 207 2013 1115 1127
12. S. Mehra, N.A. Golden, N.K. Dutta, C.C. Midkiff, X. Alvarez, and L.A. Doyle et al. Reactivation of latent tuberculosis in rhesus macaques by coinfection with simian immunodeficiency virus J. Med. Primatol. 40 2011 233 243
13. S. Mehra, N.A. Golden, K. Stuckey, P.J. Didier, L.A. Doyle, and K.E. Russell-Lodrigue et al. The Mycobacterium tuberculosis stress response factor SigH is required for bacterial burden as well as immunopathology in primate lungs J. Infect. Dis. 205 2012 1203 1213
14. M. Roodgar, A. Lackner, D. Kaushal, S. Sankaran, S. Dandekar, and J.S. Trask et al. Expression levels of 10 candidate genes in lung tissue of vaccinated and TB-infected cynomolgus macaques J. Med. Primatol. 42 2013 161 164
15. D. Kaushal, S. Mehra, P.J. Didier, and A.A. Lackner The non-human primate model of tuberculosis J. Med. Primatol. 41 2012 191 201
16. P.L. Lin, A. Myers, L. Smith, C. Bigbee, M. Bigbee, and C. Fuhrman et al. Tumor necrosis factor neutralization results in disseminated disease in acute and latent Mycobacterium tuberculosis infection with normal granuloma structure in a cynomolgus macaque model Arthritis Rheum. 62 2010 340 350
17. P.L. Lin, T. Rutledge, A.M. Green, M. Bigbee, C. Fuhrman, and E. Klein et al. CD4 T cell depletion exacerbates acute Mycobacterium tuberculosis while reactivation of latent infection is dependent on severity of tissue depletion in cynomolgus macaques AIDS Res. Hum. Retroviruses 28 2012 1693 1702
18. S. Mehra, B. Pahar, N.K. Dutta, C.N. Conerly, K. Philippi-Falkenstein, and X. Alvarez et al. Transcriptional reprogramming in nonhuman primate (rhesus macaque) tuberculosis granulomas PLoS ONE 5 2010 e12266
19. K. Sakamoto The pathology of Mycobacterium tuberculosis infection Vet. Pathol. 49 2012 423 439
20. A. O'Garra, P.S. Redford, F.W. McNab, C.I. Bloom, R.J. Wilkinson, and M.P. Berry The immune response in tuberculosis Annu. Rev. Immunol. 31 2013 475 527
21. M.H. Larsen, K. Biermann, B. Chen, T. Hsu, V.K. Sambandamurthy, and A.A. Lackner et al. Efficacy and safety of live attenuated persistent and rapidly cleared Mycobacterium tuberculosis vaccine candidates in non-human primates Vaccine 27 2009 4709 4717
22. F.A. Verreck, R.A. Vervenne, I. Kondova, K.W. van Kralingen, E.J. Remarque, and G. Braskamp et al. MVA.85A boosting of BCG and an attenuated, phoP deficient M. tuberculosis vaccine both show protective efficacy against tuberculosis in rhesus macaques PLoS ONE 4 2009 e5264
23. D. Kaushal, R.P. Bohm Jr., and A.A. Lackner How well do you know your monkeys? J. Med. Primatol. 42 2013 48 49
24. S.H. Kaufmann Tuberculosis vaccines: time to think about the next generation Semin. Immunol. 25 2013 172 181
25. E.J. Rubin The granuloma in tuberculosis - friend or foe? N. Engl. J. Med. 360 2009 2471 2473
26. L. Ramakrishnan Revisiting the role of the granuloma in tuberculosis Nat. Rev. Immunol. 12 2012 352 366
27. C. Paige, and W.R. Bishai Penitentiary or penthouse condo: the tuberculous granuloma from the microbe's point of view Cell. Microbiol. 12 2010 301 309
28. J.T. Mattila, O.O. Ojo, D. Kepka-Lenhart, S. Marino, J.H. Kim, and S.Y. Eum et al. Microenvironments in tuberculous granulomas are delineated by distinct populations of macrophage subsets and expression of nitric oxide synthase and arginase isoforms J. Immunol. 191 2013 773 784
29. D.G. Russell The evolutionary pressures that have molded Mycobacterium tuberculosis into an infectious adjuvant Curr. Opin. Microbiol. 16 2013 78 84
30. D.G. Russell, P.J. Cardona, M.J. Kim, S. Allain, and F. Altare Foamy macrophages and the progression of the human tuberculosis granuloma Nat. Immunol. 10 2009 943 948
31. J.M. Davis, and L. Ramakrishnan The role of the granuloma in expansion and dissemination of early tuberculous infection Cell 136 2009 37 49
32. R.F. Silver, J. Walrath, H. Lee, B.A. Jacobson, H. Horton, and M.R. Bowman et al. Human alveolar macrophage gene responses to Mycobacterium tuberculosis strains H37Ra and H37Rv Am. J. Respir. Cell Mol. Biol. 40 2009 491 504
33. M.A. Baird, D.N. Hart, N. Abernethy, and J.D. Watson Dendritic cell presentation of PPD and 19 kDa protein of Mycobacterium tuberculosis and emergent T helper cell phenotype Immunol. Cell Biol. 73 1995 537 543 (Pubitemid 26037499)
34. A.M. Caruso, N. Serbina, E. Klein, K. Triebold, B.R. Bloom, and J.L. Flynn Mice deficient in CD4 T cells have only transiently diminished levels of IFN-gamma, yet succumb to tuberculosis J. Immunol. 162 1999 5407 5416 (Pubitemid 29307149)
35. A. Popov, Z. Abdullah, C. Wickenhauser, T. Saric, J. Driesen, and F.G. Hanisch et al. Indoleamine 2,3-dioxygenase-expressing dendritic cells form suppurative granulomas following Listeria monocytogenes infection J. Clin. Invest. 116 2006 3160 3170 (Pubitemid 44878630)
36. Y.J. Zhang, M.C. Reddy, T.R. Ioerger, A.C. Rothchild, V. Dartois, and B.M. Schuster et al. Tryptophan biosynthesis protects mycobacteria from CD4 T-cell-mediated killing Cell 155 2013 1296 1308